The conflicting results regarding associations between tumoral B7-H3 expression and prognosis of pancreatic cancer patients reported by previous studies may also be related to the same technical issues and/or differences between patient cohorts. This evidence concerns the gene CD276 and familial pancreatic carcinoma.